FDA Inspection 806900 — Indiana Blood Center
The FDA completed an inspection of Indiana Blood Center on Nov 8, 2012 in Noblesville, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 8, 2012
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Noblesville, IN (United States)